ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,594,000 | -47.6% | 61,766 | +8.5% | 0.01% | -57.1% |
| Q4 2020 | $3,044,000 | +57.1% | 56,947 | +21.2% | 0.01% | +27.3% |
| Q3 2020 | $1,938,000 | -4.2% | 46,985 | +12.6% | 0.01% | -8.3% |
| Q2 2020 | $2,022,000 | +137.0% | 41,713 | +9.9% | 0.01% | +200.0% |
| Q1 2018 | $853,000 | -26.7% | 37,947 | -1.7% | 0.00% | -33.3% |
| Q4 2017 | $1,163,000 | -18.7% | 38,615 | +1.8% | 0.01% | -14.3% |
| Q3 2017 | $1,430,000 | -34.7% | 37,950 | -51.6% | 0.01% | +16.7% |
| Q2 2017 | $2,190,000 | +62.6% | 78,490 | +100.3% | 0.01% | -25.0% |
| Q1 2017 | $1,347,000 | -12.2% | 39,192 | 0.0% | 0.01% | -11.1% |
| Q4 2016 | $1,534,000 | -32.1% | 39,192 | -44.8% | 0.01% | -35.7% |
| Q3 2016 | $2,259,000 | +5.5% | 71,001 | +7.6% | 0.01% | 0.0% |
| Q2 2016 | $2,142,000 | – | 65,989 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |